The current FoundationOne assay examines about 315 genes known to be somatically altered in human solid tumors, as well as 28 translocations. How were these genes determined? What makes them significant?

The current FoundationOne assay examines about 315 genes known to be somatically altered in human solid tumors, as well as 28 translocations. How were these genes determined? What makes them significant?

The current FoundationOne assay examines about 315 genes known to be somatically altered in human solid tumors, as well as 28 translocations. How were these genes determined? What makes them significant?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professsor Hyun Cheol Chung, MD

Professsor Hyun Cheol Chung, MD

Professor of Medical Oncology
Director, Yonsei Song-Dang Institute for Cancer Research
Yonsei University College of Medicine
Seoul, Korea